Mitral Regurgitation Severity Grading (ASE 2017)
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۲ • واحد: cm
حداقل ۰ — حداکثر ۱.۵ • واحد: cm²
حداقل ۰ — حداکثر ۲۰۰ • واحد: mL
حداقل ۰ — حداکثر ۱۰۰ • واحد: %
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Mild—
- Moderate—
- Severe—
The Mitral Regurgitation Severity Grading (ASE 2017) calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include vc width cm. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Mitral regurgitation severity grading per ASE 2017: vena contracta width, effective regurgitant orifice area (EROA), regurgitant volume (RVol), and regurgitant fraction (RF). Overall grade = worst parameter (fail-safe direction).
Clinical Indication
The Mitral Regurgitation Severity Grading (ASE 2017) is indicated for bedside clinical practice to support Mitral regurgitation severity grading per ASE 2017: vena contracta width, effective regurgitant orifice area (EROA), regurgitant volume (RVol), and regurgitant fraction (RF). Overall grade = worst parameter (fail-safe direction).. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Quantitative thresholds assume primary (degenerative) MR; secondary MR uses lower EROA/RVol cutoffs (≥0.20 cm² / ≥30 mL) per guidelines — noted, not computed..
Severe if any: VC ≥0.7 cm, EROA ≥0.40 cm², RVol ≥60 mL, RF ≥50%. Mild if all: VC <0.3, EROA <0.20, RVol <30, RF <30. Otherwise moderate.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| vc_width_cm | float | No | Vena contracta width(cm) |
| eroa_cm2 | float | No | Effective regurgitant orifice area(cm²) |
| rvol_ml | float | No | Regurgitant volume per beat(mL) |
| rf_percent | float | No | Regurgitant fraction(%) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| — | Mild | Mild mitral regurgitation |
| — | Moderate | Moderate mitral regurgitation |
| — | Severe | Severe mitral regurgitation |
Evidence-Based References (EBM)
- Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(4):303-371.